BMC Cancer

official impact factor 3.15

Open Access Highly Access

Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report

Martin F Sprinzl*, Carl C Schimanski, Markus Moehler, Simin Schadmand-Fischer, Peter R Galle and Stephan Kanzler

BMC Cancer 2006, 6:190 doi:10.1186/1471-2407-6-190

Accesses  

  • Last 30 days: 29 accesses
  • Last 365 days: 380 accesses
  • All time: 3639 accesses